Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Experience with Biosimilar Infliximab (Remsima®) in NorwayJørgen Jahnsen, Kristin Kaasen Jørgensen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 18, 2009
[Measurement of calprotectin in faeces]Jørgen Jahnsen, Arne G Røseth, Erling Aadland
The American Journal of Gastroenterology|July 23, 2003
Body composition in patients with inflammatory bowel disease: a population-based studyJørgen Jahnsen, Jan Arvid Falch, Petter Mowinckel, et al.
Digestion|January 4, 2005
Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up studyKetil Størdal, Jørgen Jahnsen, Beint S Bentsen, et al.
Expert Review of Gastroenterology & Hepatology|September 24, 2015
Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational studyJørgen Jahnsen, Trond Espen Detlie, Simen Vatn, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 4, 2006
[Bone metabolism in patients with newly diagnosed caeliac disease]Evita Deressa, Anne Cathrine Wammer, Jan Arvid Falch, et al.
American Journal of Epidemiology|September 20, 2008
The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern NorwayGeir Aamodt, Geir Bukholm, Jørgen Jahnsen, et al.
Pageof 12